Total Payments
$58,015
2023 Payments
$15,200
Companies
6
Transactions
18
Medicare Patients
3,788
Medicare Billing
$383,603
Payment Breakdown by Category
Consulting$50,545 (87.1%)
Travel$4,341 (7.5%)
Research$3,040 (5.2%)
Food & Beverage$89.16 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $50,545 | 7 | 87.1% |
| Travel and Lodging | $4,341 | 9 | 7.5% |
| Unspecified | $3,040 | 1 | 5.2% |
| Food and Beverage | $89.16 | 1 | 0.2% |
Payments by Type
General
$54,975
17 transactions
Research
$3,040
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INSYS Therapeutics Inc | $25,400 | 10 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $12,160 | 1 | $0 (2023) |
| Braeburn Pharmaceuticals, Inc. | $11,280 | 3 | $0 (2017) |
| Scilex Pharmaceuticals Inc. | $4,334 | 2 | $0 (2018) |
| Purdue Pharma L.P. | $3,040 | 1 | $0 (2023) |
| Kaleo, Inc. | $1,800 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15,200 | 2 | Collegium Pharmaceutical, Inc. ($12,160) |
| 2018 | $15,697 | 9 | INSYS Therapeutics Inc ($9,562) |
| 2017 | $27,118 | 7 | INSYS Therapeutics Inc ($15,838) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/27/2023 | Collegium Pharmaceutical, Inc. | Xtampza (Drug), Belbuca, Nucynta | Consulting Fee | Cash or cash equivalent | $12,160.00 | General |
| Category: Opioid Analgesic | ||||||
| 04/27/2023 | Purdue Pharma L.P. | — | — | Cash or cash equivalent | $3,040.00 | Research |
| Study: PMR 3033-11: Study 11 | ||||||
| 07/11/2018 | Scilex Pharmaceuticals Inc. | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: Analgesic | ||||||
| 07/06/2018 | Scilex Pharmaceuticals Inc. | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) | Travel and Lodging | Cash or cash equivalent | $834.26 | General |
| Category: Analgesic | ||||||
| 05/01/2018 | INSYS Therapeutics Inc | — | Consulting Fee | Cash or cash equivalent | $8,505.00 | General |
| 05/01/2018 | INSYS Therapeutics Inc | — | Travel and Lodging | In-kind items and services | $98.45 | General |
| 04/11/2018 | INSYS Therapeutics Inc | — | Food and Beverage | In-kind items and services | $89.16 | General |
| 04/09/2018 | INSYS Therapeutics Inc | — | Travel and Lodging | In-kind items and services | $591.14 | General |
| 04/09/2018 | INSYS Therapeutics Inc | — | Travel and Lodging | In-kind items and services | $158.49 | General |
| 04/09/2018 | INSYS Therapeutics Inc | — | Travel and Lodging | In-kind items and services | $120.00 | General |
| 01/15/2018 | Kaleo, Inc. | Evzio (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Opioid Antagonist | ||||||
| 12/15/2017 | INSYS Therapeutics Inc | Cannabidiol Oral Solution (OS) (Drug) | Consulting Fee | Cash or cash equivalent | $8,505.00 | General |
| 12/15/2017 | INSYS Therapeutics Inc | Cannabidiol Oral Solution (OS) (Drug) | Travel and Lodging | In-kind items and services | $487.95 | General |
| 11/14/2017 | Braeburn Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 11/14/2017 | Braeburn Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $988.78 | General |
| 11/14/2017 | Braeburn Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $291.40 | General |
| 09/22/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Consulting Fee | Cash or cash equivalent | $6,075.00 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 09/22/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Travel and Lodging | In-kind items and services | $770.16 | General |
| Category: Breakthrough Cancer Pain | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PMR 3033-11: Study 11 | Purdue Pharma L.P. | $3,040 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 858 | 1,239 | $465,118 | $82,769 |
| 2022 | 18 | 1,063 | 1,487 | $564,745 | $103,446 |
| 2021 | 16 | 1,141 | 1,810 | $647,302 | $130,353 |
| 2020 | 12 | 726 | 1,280 | $358,553 | $67,034 |
Total Patients
3,788
Total Services
5,816
Medicare Billing
$383,603
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 312 | $126,230 | $24,377 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 215 | 309 | $84,856 | $16,265 | 19.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 149 | 149 | $91,337 | $15,388 | 16.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 74 | 107 | $43,121 | $7,824 | 18.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 42 | 60 | $30,960 | $4,645 | 15.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 23 | 31 | $22,197 | $2,997 | 13.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 28 | 64 | $15,953 | $2,820 | 17.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $11,092 | $1,941 | 17.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 23 | 31 | $12,912 | $1,726 | 13.4% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 33 | 45 | $7,978 | $1,517 | 19.0% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 28 | 63 | $7,078 | $1,445 | 20.4% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 23 | 26 | $6,292 | $988.37 | 15.7% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 11 | 12 | $5,112 | $835.92 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 187 | 187 | $109,672 | $21,980 | 20.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 147 | 210 | $87,066 | $17,893 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 204 | 320 | $87,175 | $17,446 | 20.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 109 | 164 | $47,200 | $8,688 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 86 | $34,422 | $6,636 | 19.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 53 | 73 | $35,116 | $6,077 | 17.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 37 | 53 | $38,505 | $5,281 | 13.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 32 | 80 | $17,712 | $3,421 | 19.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 11 | 17 | $18,571 | $2,778 | 15.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 35 | 50 | $20,471 | $2,763 | 13.5% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 34 | 81 | $8,964 | $1,908 | 21.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $8,344 | $1,664 | 19.9% |
About Dr. Edward Michna, MD
Dr. Edward Michna, MD is a Anesthesiology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447240528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Michna, MD has received a total of $58,015 in payments from pharmaceutical and medical device companies, with $15,200 received in 2023. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($50,545).
As a Medicare-enrolled provider, Michna has provided services to 3,788 Medicare beneficiaries, totaling 5,816 services with total Medicare billing of $383,603. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Boston, MA
- Active Since 10/28/2005
- Last Updated 11/02/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1447240528
Products in Payments
- Xtampza (Drug) $12,160
- Cannabidiol Oral Solution (OS) (Drug) $8,993
- SUBSYS (Drug) $6,845
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $4,334
- Evzio (Drug) $1,800
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Boston
Michael Dambra, Md, MD
Anesthesiology — Payments: $1.0M
Anesthesiology $1.0M
Dr. John Marota, Phd Md, PHD MD
Anesthesiology — Payments: $321,359
Anesthesiology $321,359
Dr. Robert Truog, Md, MD
Anesthesiology — Payments: $307,049
Anesthesiology $307,049
Douglas Shook, Md, MD
Anesthesiology — Payments: $275,595
Anesthesiology $275,595
Robert Yong, M.d, M.D
Anesthesiology — Payments: $255,932
Anesthesiology $255,932
Edgar Ross, Md, MD
Anesthesiology — Payments: $158,065
Anesthesiology $158,065